Page 36 - 2016-2021-ASU
P. 36

drugs purchased at a retail pharmacy or the mail service pharmacy for up

            to a 30-day supply shall be as follows:

                 • $5 Generic/Level One
                 • $25 Preferred-Brand/Level Two ($30 effective 1/1/19)

                 • $45 Non-Preferred Brand/Level Three ($60 effective 1/1/19)
               When a brand-name prescription drug is dispensed and an FDA-approved

            generic  equivalent is  available, the  member  will be responsible  for the
            difference in cost between the generic drug and the non-preferred brand-

            name drug, plus the non-preferred brand-name copayment.
               The copayment for prescription drugs purchased at a retail pharmacy for

            a 31-90 day supply shall be as follows:
                 • $10 Generic/Level One

                 • $50 Preferred Brand/Level Two ($60 effective 1/1/19)
                 • $90 Non-Preferred Brand/Level Three ($120 effective 1/1/19)

               When a brand-name prescription drug is dispensed and an FDA-approved
            generic  equivalent is  available, the  member  will be responsible  for the

            difference in cost between the generic drug and the non-preferred brand-
            name drug, plus the non-preferred brand-name copayment.

               The copayment for prescription drugs purchased through the mail service
            pharmacy for a 31-90 day supply will be as follows:

                 • $5 Generic/Level One

                 • $50 Preferred Brand/Level Two ($55 effective 1/1/19)
                 •$90 Non-Preferred Brand/Level Three ($110 effective 1/1/19)
                 When a brand-name prescription drug  is dispensed and an FDA-

            approved generic equivalent is available, the member will be responsible

            for the difference in cost between the generic drug and the non-preferred
            brand-name drug, plus the non-preferred brand-name copayment.

               (b)  New-to-you  prescriptions  will  require  two  30  day  fills  at  a  retail
            setting prior to being able to obtain a 90 day fill through retail or mail.  This

            program will be discontinued no later than January 1, 2019.
               (c) Drugs considered to be “specialty drugs” (including but not limited to

            drugs requiring special handling, special administration and/or intensive
            patient monitoring and biotech drugs developed from human cell proteins

            and DNA) will be dispensed through the Empire Plan Specialty Pharmacy
            Program.

                 • Enrollees may fill one prescription for a  drug included in  the


                                                               35
   31   32   33   34   35   36   37   38   39   40   41